Searched for: school:SOM
Department/Unit:Neurology
Cerebellar Functional Anatomy: a Didactic Summary Based on Human fMRI Evidence [Editorial]
Guell, Xavier; Schmahmann, Jeremy
The cerebellum is relevant for virtually all aspects of behavior in health and disease. Cerebellar findings are common across all kinds of neuroimaging studies of brain function and dysfunction. A large and expanding body of literature mapping motor and non-motor functions in the healthy human cerebellar cortex using fMRI has served as a tool for interpreting these findings. For example, results of cerebellar atrophy in Alzheimer's disease in caudal aspects of Crus I/II and medial lobule IX can be interpreted by consulting a large number of task, resting-state, and gradient-based reports that describe the functional characteristics of these specific aspects of the cerebellar cortex. Here, we provide a concise summary that outlines organizational principles observed consistently across these studies of normal cerebellar organization. This basic framework may be useful for investigators performing or reading experiments that require a functional interpretation of human cerebellar topography.
PMID: 31707620
ISSN: 1473-4230
CID: 5454262
A Pilot Randomized Controlled Trial to Assess the Impact of Motivational Interviewing on Initiating Behavioral Therapy for Migraine
Minen, Mia T; Sahyoun, Gabriella; Gopal, Ariana; Levitan, Valeriya; Pirraglia, Elizabeth; Simon, Naomi M; Halpern, Audrey
BACKGROUND:Relaxation, biofeedback, and cognitive behavioral therapy are evidence-based behavioral therapies for migraine. Despite such efficacy, research shows that only about half of patients initiate behavioral therapy recommended by their headache specialists. OBJECTIVE:Motivational interviewing (MI) is a widely used method to help patients explore and overcome ambivalence to enact positive life changes. We tested the hypothesis that telephone-based MI would improve initiation, scheduling, and attending behavioral therapy for migraine. METHODS:Single-blind randomized controlled trial comparing telephone-based MI to treatment as usual (TAU). Participants were recruited during their appointments with headache specialists at two sites of a New York City medical center. INCLUSION CRITERIA/METHODS:ages from 16 to 80, migraine diagnosis by United Council of Neurologic Subspecialty fellowship trained and/or certified headache specialist, and referral for behavioral therapy for prevention in the appointment of recruitment. EXCLUSION CRITERIA/METHODS:having done behavioral therapy for migraine in the past year. Participants in the MI group received up to 5 MI calls. TAU participants were called after 3 months for general follow-up data. The prespecified primary outcome was scheduling a behavioral therapy appointment, and secondary outcomes were initiating and attending a behavioral therapy appointment. RESULTS:76 patients were enrolled and randomized (MI = 36, TAU = 40). At baseline, the mean number of headache days was 12.0 ± 9.0. Self-reported anxiety was present for 36/52 (69.2%) and depression for 30/52 (57.7%). Follow-up assessments were completed for 77.6% (59/76, MI = 32, TAU = 27). The mean number of MI calls per participant was 2.69 ± 1.56 [0 to 5]. There was a greater likelihood of those in the MI group to initiating an appointment (22/32, 68.8% vs 11/27, 40.7%, P = .0309). There were no differences in appointment scheduling or attendance. Reasons stated for not initiating behavioral therapy were lack of time, lack of insurance/funding, prioritizing other treatments, and travel plans. CONCLUSIONS:Brief telephone-based MI may improve rates of initiation of behavioral therapy for migraine, but other barriers appear to lessen the impact on scheduling and attending behavioral therapy appointments.
PMID: 31981227
ISSN: 1526-4610
CID: 4274212
Differences in Admission Blood Pressure Among Causes of Intracerebral Hemorrhage
Lin, Jessica; Piran, Pirouz; Lerario, Mackenzie P; Ong, Hanley; Gupta, Ajay; Murthy, Santosh B; DÃaz, Iván; Stieg, Philip E; Knopman, Jared; Falcone, Guido J; Sheth, Kevin N; Fink, Matthew E; Merkler, Alexander E; Kamel, Hooman
Background and Purpose- It is unknown whether admission systolic blood pressure (SBP) differs among causes of intracerebral hemorrhage (ICH). We sought to elucidate an association between admission BP and ICH cause. Methods- We compared admission SBP across ICH causes among patients in the Cornell Acute Stroke Academic Registry, which includes all adults with ICH at our center from 2011 through 2017. Trained analysts prospectively collected demographics, comorbidities, and admission SBP, defined as the first recorded value in the emergency department or on transfer from another hospital. ICH cause was adjudicated by a panel of neurologists using the SMASH-U criteria. We used ANOVA to compare mean admission SBP among ICH causes. We used multiple linear regression to adjust for age, sex, race, Glasgow Coma Scale score, and hematoma size. In secondary analyses, we compared hourly SBP measurements during the first 72 hours after admission, using mixed-effects linear models adjusted for the covariates above plus antihypertensive agents. Results- Among 484 patients with ICH, admission SBP varied significantly across ICH causes, ranging from 138 (±24) mm Hg in those with structural vascular lesions to 167 (±35) mm Hg in those with hypertensive ICH (P<0.001). The mean admission SBP in hypertensive ICH was 17 (95% CI, 11-24) mm Hg higher than in ICH of all other causes combined. These differences remained significant after adjustment for age, sex, race, Glasgow Coma Scale score, and hematoma size (P<0.001), and this persisted throughout the first 72 hours of hospitalization (P<0.001). Conclusions- In a single-center ICH registry, SBP varied significantly among ICH causes, both on admission and during hospitalization. Our results suggest that BP in the acute post-ICH setting is at least partly associated with ICH cause rather than simply representing a physiological reaction to the ICH itself.
PMID: 31818231
ISSN: 1524-4628
CID: 4889742
Motor-cognitive approach and aerobic training: a synergism for rehabilitative intervention in Parkinson's disease
Ferrazzoli, Davide; Ortelli, Paola; Cucca, Alberto; Bakdounes, Leila; Canesi, Margherita; Volpe, Daniele
Parkinson's disease (PD) results in a complex deterioration of motor behavior. Effective pharmacological or surgical treatments addressing the whole spectrum of both motor and cognitive symptoms are lacking. The cumulative functional impairment may have devastating socio-economic consequences on both patients and caregivers. Comprehensive models of care based on multidisciplinary approaches may succeed in better addressing the overall complexity of PD. Neurorehabilitation is a highly promising non-pharmacological intervention for managing PD. The scientific rationale beyond rehabilitation and its practical applicability remain to be established. In the present perspective, we aim to discuss the current evidence supporting integrated motor-cognitive and aerobic rehabilitation approaches for patients with PD while suggesting a practical framework to optimize this intervention in the next future.
PMID: 32039653
ISSN: 1758-2032
CID: 4304142
Letter to the Editor re: Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter [Letter]
Zanotti-Fregonara, Paolo; Veronese, Mattia; Rizzo, Gaia; Pascual, Belen; Masdeu, Joseph C; Turkheimer, Federico E
PMID: 31641965
ISSN: 1860-2002
CID: 4147402
New routes of dopaminergic drug delivery in patients with Parkinson's disease
Antonini, Angelo
PMID: 31818698
ISSN: 1474-4465
CID: 4234202
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
Weiss, Scott L; Peters, Mark J; Alhazzani, Waleed; Agus, Michael S D; Flori, Heidi R; Inwald, David P; Nadel, Simon; Schlapbach, Luregn J; Tasker, Robert C; Argent, Andrew C; Brierley, Joe; Carcillo, Joseph; Carrol, Enitan D; Carroll, Christopher L; Cheifetz, Ira M; Choong, Karen; Cies, Jeffry J; Cruz, Andrea T; De Luca, Daniele; Deep, Akash; Faust, Saul N; De Oliveira, Claudio Flauzino; Hall, Mark W; Ishimine, Paul; Javouhey, Etienne; Joosten, Koen F M; Joshi, Poonam; Karam, Oliver; Kneyber, Martin C J; Lemson, Joris; MacLaren, Graeme; Mehta, Nilesh M; Møller, Morten Hylander; Newth, Christopher J L; Nguyen, Trung C; Nishisaki, Akira; Nunnally, Mark E; Parker, Margaret M; Paul, Raina M; Randolph, Adrienne G; Ranjit, Suchitra; Romer, Lewis H; Scott, Halden F; Tume, Lyvonne N; Verger, Judy T; Williams, Eric A; Wolf, Joshua; Wong, Hector R; Zimmerman, Jerry J; Kissoon, Niranjan; Tissieres, Pierre
OBJECTIVES/OBJECTIVE:To develop evidence-based recommendations for clinicians caring for children (including infants, school-aged children, and adolescents) with septic shock and other sepsis-associated organ dysfunction. DESIGN/METHODS:A panel of 49 international experts, representing 12 international organizations, as well as three methodologists and three public members was convened. Panel members assembled at key international meetings (for those panel members attending the conference), and a stand-alone meeting was held for all panel members in November 2018. A formal conflict-of-interest policy was developed at the onset of the process and enforced throughout. Teleconferences and electronic-based discussion among the chairs, co-chairs, methodologists, and group heads, as well as within subgroups, served as an integral part of the guideline development process. METHODS:The panel consisted of six subgroups: recognition and management of infection, hemodynamics and resuscitation, ventilation, endocrine and metabolic therapies, adjunctive therapies, and research priorities. We conducted a systematic review for each Population, Intervention, Control, and Outcomes question to identify the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak, or as a best practice statement. In addition, "in our practice" statements were included when evidence was inconclusive to issue a recommendation, but the panel felt that some guidance based on practice patterns may be appropriate. RESULTS:The panel provided 77 statements on the management and resuscitation of children with septic shock and other sepsis-associated organ dysfunction. Overall, six were strong recommendations, 52 were weak recommendations, and nine were best-practice statements. For 13 questions, no recommendations could be made; but, for 10 of these, "in our practice" statements were provided. In addition, 49 research priorities were identified. CONCLUSIONS:A large cohort of international experts was able to achieve consensus regarding many recommendations for the best care of children with sepsis, acknowledging that most aspects of care had relatively low quality of evidence resulting in the frequent issuance of weak recommendations. Despite this challenge, these recommendations regarding the management of children with septic shock and other sepsis-associated organ dysfunction provide a foundation for consistent care to improve outcomes and inform future research.
PMID: 32032273
ISSN: 1529-7535
CID: 4300872
Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
Weiss, Scott L; Peters, Mark J; Alhazzani, Waleed; Agus, Michael S D; Flori, Heidi R; Inwald, David P; Nadel, Simon; Schlapbach, Luregn J; Tasker, Robert C; Argent, Andrew C; Brierley, Joe; Carcillo, Joseph; Carrol, Enitan D; Carroll, Christopher L; Cheifetz, Ira M; Choong, Karen; Cies, Jeffry J; Cruz, Andrea T; De Luca, Daniele; Deep, Akash; Faust, Saul N; De Oliveira, Claudio Flauzino; Hall, Mark W; Ishimine, Paul; Javouhey, Etienne; Joosten, Koen F M; Joshi, Poonam; Karam, Oliver; Kneyber, Martin C J; Lemson, Joris; MacLaren, Graeme; Mehta, Nilesh M; Møller, Morten Hylander; Newth, Christopher J L; Nguyen, Trung C; Nishisaki, Akira; Nunnally, Mark E; Parker, Margaret M; Paul, Raina M; Randolph, Adrienne G; Ranjit, Suchitra; Romer, Lewis H; Scott, Halden F; Tume, Lyvonne N; Verger, Judy T; Williams, Eric A; Wolf, Joshua; Wong, Hector R; Zimmerman, Jerry J; Kissoon, Niranjan; Tissieres, Pierre
PMID: 32032264
ISSN: 1529-7535
CID: 4300862
Preventing catastrophic injury and death in collegiate athletes: interassociation recommendations endorsed by 13 medical and sports medicine organisations
Parsons, John T; Anderson, Scott A; Casa, Douglas J; Hainline, Brian
The Second Safety in College Football Summit resulted in interassociation consensus recommendations for three paramount safety issues in collegiate athletics: (1) independent medical care for collegiate athletes; (2) diagnosis and management of sport-related concussion; and (3) year-round football practice contact for collegiate athletes. This document, the fourth arising from the 2016 event, addresses the prevention of catastrophic injury, including traumatic and non-traumatic death, in collegiate athletes. The final recommendations in this document are the result of presentations and discussions on key items that occurred at the summit. After those presentations and discussions, endorsing organisation representatives agreed on 18 foundational statements that became the basis for this consensus paper that has been subsequently reviewed by relevant stakeholders and endorsing organisations. This is the final endorsed document for preventing catastrophic injury and death in collegiate athletes. This document is divided into the following components. (1) Background-this section provides an overview of catastrophic injury and death in collegiate athletes. (2) Interassociation recommendations: preventing catastrophic injury and death in collegiate athletes-this section provides the final recommendations of the medical organisations for preventing catastrophic injuries in collegiate athletes. (3) Interassociation recommendations: checklist-this section provides a checklist for each member school. The checklist statements stem from foundational statements voted on by representatives of medical organisations during the summit, and they serve as the primary vehicle for each member school to implement the prevention recommendations. (4) References-this section provides the relevant references for this document. (5) Appendices-this section lists the foundational statements, agenda, summit attendees and medical organisations that endorsed this document.
PMID: 31537549
ISSN: 1473-0480
CID: 4175212
Management of Orthostatic Hypotension
Palma, Jose-Alberto; Kaufmann, Horacio
PURPOSE OF REVIEW/OBJECTIVE:This article reviews the management of orthostatic hypotension with emphasis on neurogenic orthostatic hypotension. RECENT FINDINGS/RESULTS:Establishing whether the cause of orthostatic hypotension is a pathologic lesion in sympathetic neurons (ie, neurogenic orthostatic hypotension) or secondary to other medical causes (ie, non-neurogenic orthostatic hypotension) can be achieved by measuring blood pressure and heart rate at the bedside. Whereas fludrocortisone has been extensively used as first-line treatment in the past, it is associated with adverse events including renal and cardiac failure and increased risk of all-cause hospitalization. Distinguishing whether neurogenic orthostatic hypotension is caused by central or peripheral dysfunction has therapeutic implications. Patients with peripheral sympathetic denervation respond better to norepinephrine agonists/precursors such as droxidopa, whereas patients with central autonomic dysfunction respond better to norepinephrine reuptake inhibitors. SUMMARY/CONCLUSIONS:Management of orthostatic hypotension is aimed at improving quality of life and reducing symptoms rather than at normalizing blood pressure. Nonpharmacologic measures are the key to success. Pharmacologic options include volume expansion with fludrocortisone and sympathetic enhancement with midodrine, droxidopa, and norepinephrine reuptake inhibitors. Neurogenic supine hypertension complicates management of orthostatic hypotension and is primarily ameliorated by avoiding the supine position and sleeping with the head of the bed elevated.
PMID: 31996627
ISSN: 1538-6899
CID: 4315312